Rickie Conrady, MD
Geriatric Medicine · Edmond, OKNPI 1316913510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $176 and has fallen 57.8% since, to $74 in 2025.
Across 19 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$72
- Boehringer Ingelheim$62
- Lilly USA, LLC$52
- GSK$50
- Pfizer$37
- Abiomed$27
- plus $58 from 3 others
Across 26 payments — averaging $410.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kowa Research Institute, Inc.$11K
What the payments were for
- Food & beverage$359100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 4 | $72 |
| Boehringer Ingelheim | 4 | $62 |
| Lilly USA, LLC | 2 | $52 |
| GSK | 3 | $50 |
| Pfizer | 2 | $37 |
| Abiomed | 1 | $27 |
| Medtronic | 1 | $25 |
| Abbott | 1 | $19 |
| Amgen | 1 | $15 |
How this compares
$359 in reported general payments places this provider in the 55th percentile of 25 geriatric medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 100 | $130,286 |
| MounjaroTirzepatide | 55 | $63,677 |
| JardianceEmpagliflozin | 34 | $58,626 |
| TrulicityDulaglutide | 41 | $52,469 |
| XareltoRivaroxaban | 27 | $30,757 |
| Breo ElliptaFluticasone/Vilanterol | 45 | $29,704 |
| OzempicSemaglutide | 27 | $28,254 |
| FarxigaDapagliflozin Propanediol | 17 | $21,384 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $16,761 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $15,676 |
| Atorvastatin Calcium | 517 | $13,165 |
| Xtampza ErOxycodone Myristate | 13 | $12,661 |
| TradjentaLinagliptin | 15 | $11,709 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $9,256 |
| Spiriva HandihalerTiotropium Bromide | 11 | $8,559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $37 | $130,286100 claims |
| Lilly USA, LLCMounjaro, Trulicity | $52 | $116,14596 claims |
| Boehringer IngelheimJardiance, Tradjenta | $62 | $70,33549 claims |
| GSKBreo Ellipta, Anoro Ellipta, Arnuity Ellipta | $50 | $52,88480 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 25 geriatric medicine providers in Oklahoma.
Other geriatric medicine in Edmond
- Larry BalzerEdmond$2K
- Insung KimTulsa$7K
- Kenneth KirkTulsa$2K
- Laurence RubensteinOklahoma City$2K
- Padmashree VeluryLawton$1K
- Lisa DuckettTulsa$629
- David KraftTulsa$512
- Madison AndrewsOklahoma City$489
- Karen RossOklahoma City$438
- Thomas ConklinStigler$416
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.